Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Insight into the way pain is regulated in the brain could lead to new target for therapy

17.07.2003


A UCSF-led team has demonstrated that the cerebral cortex, the site of higher cognitive functions, not only perceives pain, but plays a role in regulating pain, and that it does so in part through the inhibitory neurotransmitter GABA, suggesting a possible target for therapy.



The finding, published in the July 17 issue of Nature, provides some of the first neuroanatomical evidence that the cerebral cortex not only receives pain signals from nerve cells in lower regions of the brain, but modulates pain signals.

"Our finding suggests that the cerebral cortex is not just the end-point of pain processing. The activity of the cortex can change the set-point of the pain threshold in a top-down manner, completely modifying the experience of pain," says lead author Luc Jasmin, MD, PhD, FRCS, UCSF assistant professor of neurological surgery.


Traditionally, pain researchers have focused their research on the lower portion of the nervous system, as pain signals originate in the periphery – i.e., in the skin and other organs – and are transmitted into the spinal cord before being relayed to the brain. Intercepting pain signals at this early stage theoretically should prove effective in treating pain conditions.

However, the causes of many forms of chronic pain have proven elusive and the pain difficult to treat. In recent years, scientists have found that stimulating the cerebral cortex diminishes pain in patients with some forms of chronic pain, such as post-stroke pain syndromes, but they have not known how the relief occurs.

In the current study, conducted in normal rats, the scientists sought insight into this phenomenon by focusing on a small region of the cerebral cortex known as the rostral agranular insular cortex (RAIC), one of the few cortical areas consistently activated by painful stimuli. As GABA (gamma-aminobutyric acid), the major inhibitory neurotransmitter, or neurochemical messenger, of the brain, is prolific in the RAIC, the scientists reasoned that manipulating levels of the neurotransmitter could shed light on the way in which the RAIC might modulate pain.

The results were dramatic. When the scientists increased levels of GABA throughout the RAIC -- either by slowing the neurochemical’s normal metabolism until it accumulated over hours or by expressing a gene (GAD 67) that encodes an enzyme that synthesizes GABA -- the animals displayed a clear and consistent analgesia (insensitivity to pain), as seen in the fact that they did not withdraw their paws from a hot surface. When the increase in GABA was sustained by injecting the GAD 67 gene in neuronal and glial cells (i.e., gene therapy), the animals showed analgesia up to 10 days, suggesting that GABA works through neural mechanisms that do not down-regulate over time.

Moreover, when the scientists blocked transmission of signals through the descending pain inhibitory system, which extends from the RAIC to the spinal cord, the analgesic effect was reversed, indicating that GABA worked at least in part through this system to enhance the inhibition of the neurons that incited pain.

The investigators subsequently determined that when GABA acted through the descending pain inhibitory system it worked through neurons that have GABA-A receptors and that project to a region of the brain stem known as the locus coeruleus.

But they also determined that a large number of RAIC neurons expressing GABA-B receptors project to a brain region known as the amygdala, a site involved in pain, fear and attention processes, and this led them to explore the role that GABA might have in this pathway. The results were notable. After increasing GABA in the RAIC, the scientists selectively disinhibited GABA-B bearing RAIC neurons that projected to the amygdala. As a result, the animals experienced pain. When the activation was reversed, the pain was abolished, indicating that the neural projections from the RAIC to the amygdala play a key role in initiating pain.

"This finding demonstrates that the change in pain level works through two separate systems, with opposite effects. If the activity of the locus coeruleus is increased, analgesia occurs. If the activity of the amygdala is increased, pain occurs," says senior author Peter O’Hara, PhD, UCSF associate professor of anatomy. "This dual effect is probably a defining feature of pain modulation, and we speculate that an imbalance in the cortical output is likely to underlay some chronic pain states."

In chronic pain patients, the pathway from the RAIC to the amygdala is more likely to be the one disregulated, says Jasmin, because the one from the RAIC to the locus coeruleus appears to be involved only in the response to an acute stimulus delivered over the course of a few minutes.

The rats in the study showed less pain when GABA was increased due to their decreased perception of the stimulus and their diminished fear of it.

But Jasmin says that it is also possible that the animals were simply paying less attention to the painful stimuli, a phenomenon that has been reported in humans. One study he cites demonstrated that Israeli children who were receiving dialysis for their diabetes reported less discomfort when they were watching TV.

"We know that pain perception can be altered by mood, attention and cognition, but we know little of the neural mechanisms underlying cortical modulation of pain," says Jasmin.

In upcoming work, Jasmin and O’Hara will examine the impact of GABA delivery to the RAIC on the pain threshold of rats with chronic pain conditions such as chronic inflammation, as occurs in rheumatoid arthritis, and chronic nerve injury, as occurs from diabetes and shingles. The team will examine whether sustained expression of the GAD gene in the RAIC will produce prolonged analgesia. They also will look specifically at the impact of GABA on the amygdala, and whether it changes the animals’ alertness to sensory stimuli, i.e., a hot surface.

In the future, predicts Jasmin, gene therapy to increase levels of GABA in various areas of the brain will be used to treat pain, Parkinson’s disease and epileptic seizures.

Jennifer O’Brien | EurekAlert!
Further information:
http://www.ucsf.edu

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>